StockData
CalciMedica, Inc. logo

CalciMedica, Inc. (CALC) stock

CALCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 1/30
$1.22+0.03 (+2.52%)

Close on Nov 17, 2026Market cap $41.65MP/E –Yield –

CalciMedica operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

CalciMedica's operating income for the twelve months ending Jun 30, 2026 was -$19.63M. For fiscal 2025 it was -$23.12M. The highest annual figure on record is -$14.19M in fiscal 2022.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$23.12M–
FY2024Dec 31, 2024-$24.20M–
FY2023Dec 31, 2023-$38.08M–
FY2022Dec 31, 2022-$14.19M–
FY2021Dec 31, 2021-$35.95M–
FY2020Dec 31, 2020-$29.83M–
FY2019Dec 31, 2019-$37.50M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$4.01M–
Q1 FY2026Mar 31, 2026-$5.61M–
Q4 FY2025Dec 31, 2025-$4.39M–
Q3 FY2025Sep 30, 2025-$5.62M–
Q2 FY2025Jun 30, 2025-$6.62M–
Q1 FY2025Mar 31, 2025-$6.50M–
Q4 FY2024Dec 31, 2024-$6.17M–
Q3 FY2024Sep 30, 2024-$5.74M–
Q2 FY2024Jun 30, 2024-$6.53M–
Q1 FY2024Mar 31, 2024-$5.77M–
Q4 FY2023Dec 31, 2023-$4.32M–
Q3 FY2023Sep 30, 2023-$4.83M–
Q2 FY2023Jun 30, 2023-$6.58M–
Q1 FY2023Mar 31, 2023-$22.34M–
Q2 FY2022Jun 30, 2022-$3.59M–
Q1 FY2022Mar 31, 2022-$4.21M–
Q4 FY2021Dec 31, 2021-$8.70M–
Q3 FY2021Sep 30, 2021-$8.02M–
Q2 FY2021Jun 30, 2021-$7.74M–
Q1 FY2021Mar 31, 2021-$11.49M–
Q4 FY2020Dec 31, 2020-$9.18M–
Q3 FY2020Sep 30, 2020-$6.82M–
Q2 FY2020Jun 30, 2020-$6.04M–
Q1 FY2020Mar 31, 2020-$7.80M–
Q4 FY2019Dec 31, 2019-$10.53M–
Q3 FY2019Sep 30, 2019-$10.37M–

More CalciMedica figures

See a number that looks wrong?